Gilbert Halley E
CIK 0001601360
Chief Legal OfficerDirector
Filings
15
Latest Nov 21, 2025
Issuers covered
4
Showing
15 of 15
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 0% | -7.5% | -7.5% | -5.6% | -9.4% |
| 90 days | 2 | 50% | -25.1% | -25.1% | +2.3% | -52.5% |
| 180 days | 2 | 50% | +0.9% | +0.9% | +28.6% | -26.8% |
| 365 days | 1 | 100% | +52.0% | +52.0% | +52.0% | +52.0% |
Issuers
Companies where Gilbert Halley E has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | 5 | Nov 21, 2025 |
| PCVX | Vaxcyte, Inc. | 5 | Jun 16, 2025 |
| CTMX | Cytomx Therapeutics, Inc. | 4 | Jun 13, 2025 |
| NEO | Neogenomics Inc | 1 | Mar 3, 2022 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|